Cargando…

Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia

IMPORTANCE: Individual conditions have been identified as risk factors for dementia; however, it is important to consider the role of multimorbidity, as conditions often co-occur. OBJECTIVE: To investigate whether multimorbidity is associated with incident dementia and whether associations vary by d...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvin, Catherine M., Conroy, Megan C., Moore, Sarah F., Kuźma, Elżbieta, Littlejohns, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490497/
https://www.ncbi.nlm.nih.gov/pubmed/36125811
http://dx.doi.org/10.1001/jamanetworkopen.2022.32124
_version_ 1784793098239344640
author Calvin, Catherine M.
Conroy, Megan C.
Moore, Sarah F.
Kuźma, Elżbieta
Littlejohns, Thomas J.
author_facet Calvin, Catherine M.
Conroy, Megan C.
Moore, Sarah F.
Kuźma, Elżbieta
Littlejohns, Thomas J.
author_sort Calvin, Catherine M.
collection PubMed
description IMPORTANCE: Individual conditions have been identified as risk factors for dementia; however, it is important to consider the role of multimorbidity, as conditions often co-occur. OBJECTIVE: To investigate whether multimorbidity is associated with incident dementia and whether associations vary by different clusters of disease and genetic risk for dementia. DESIGN, SETTING, AND PARTICIPANTS: This population-based prospective cohort study used data from the UK Biobank cohort, with baseline data collected between 2006 and 2010 and with up to 15 years of follow-up. Participants included women and men without dementia and aged at least 60 years at baseline. Medical conditions were captured as part of nurse-led verbal interviews conducted at baseline assessment centers. Data were analyzed from October 2020 to July 2022. EXPOSURES: The presence of at least 2 long-term conditions from a preselected list of 42 conditions was used to define multimorbidity. High genetic risk for dementia was based on presence of 1 or 2 apolipoprotein (APOE) ε4 alleles. MAIN OUTCOMES AND MEASURES: The main outcome, incident dementia, was derived from hospital inpatient and death registry records. Associations of multimorbidity with dementia were assessed with Cox proportional hazards models. RESULTS: A total of 206 960 participants (mean [SD] age, 64.1 [2.9] years, 108 982 [52.7%] women) were included in the final sample, of whom 89 201 participants (43.1%) had multimorbidity. Over a mean (SD) of 11.8 (2.2) years of follow-up, 6182 participants (3.0%) developed dementia. The incidence rate was 1.87 (95% CI, 1.80-1.94) per 1000 person-years for those without multimorbidity and 3.41 (95% CI, 3.30-3.53) per 1000 person-years for those with multimorbidity. In Cox proportional hazards models adjusted for age, sex, ethnicity, education, socioeconomic status, and APOE-ε4 carrier status, multimorbidity was associated with an increased risk of incident dementia (hazard ratio [HR], 1.63 [95% CI, 1.55-1.71]). The highest dementia risk was observed for the hypertension, diabetes, and coronary heart disease cluster (HR, 2.20 [95% CI, 1.98-2.46]) and pain, osteoporosis, and dyspepsia cluster (HR, 2.00 [95% CI, 1.68-2.37]) in women and in the diabetes and hypertension cluster (HR, 2.24 [95% CI, 1.97-2.55]) and coronary heart disease, hypertension, and stroke cluster (HR, 1.94 [95% CI, 1.71-2.20]) in men, compared with no multimorbidity. The associations between multimorbidity and dementia were greater in those with a lower genetic risk of dementia (HR, 1.96 [95% CI, 1.81-2.11]) than in those with a higher genetic risk of dementia (HR, 1.39 [95% CI, 1.30-1.49]). Similar findings were observed when stratifying diseases clusters by genetic risk for dementia. CONCLUSIONS AND RELEVANCE: These findings suggest that multimorbidity was associated with an increased risk of dementia. The associations varied by clusters of disease and genetic risk for dementia. These findings could help with the identification of individuals at high risk of dementia as well as the development of targeted interventions to reduce or delay dementia incidence.
format Online
Article
Text
id pubmed-9490497
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-94904972022-10-05 Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia Calvin, Catherine M. Conroy, Megan C. Moore, Sarah F. Kuźma, Elżbieta Littlejohns, Thomas J. JAMA Netw Open Original Investigation IMPORTANCE: Individual conditions have been identified as risk factors for dementia; however, it is important to consider the role of multimorbidity, as conditions often co-occur. OBJECTIVE: To investigate whether multimorbidity is associated with incident dementia and whether associations vary by different clusters of disease and genetic risk for dementia. DESIGN, SETTING, AND PARTICIPANTS: This population-based prospective cohort study used data from the UK Biobank cohort, with baseline data collected between 2006 and 2010 and with up to 15 years of follow-up. Participants included women and men without dementia and aged at least 60 years at baseline. Medical conditions were captured as part of nurse-led verbal interviews conducted at baseline assessment centers. Data were analyzed from October 2020 to July 2022. EXPOSURES: The presence of at least 2 long-term conditions from a preselected list of 42 conditions was used to define multimorbidity. High genetic risk for dementia was based on presence of 1 or 2 apolipoprotein (APOE) ε4 alleles. MAIN OUTCOMES AND MEASURES: The main outcome, incident dementia, was derived from hospital inpatient and death registry records. Associations of multimorbidity with dementia were assessed with Cox proportional hazards models. RESULTS: A total of 206 960 participants (mean [SD] age, 64.1 [2.9] years, 108 982 [52.7%] women) were included in the final sample, of whom 89 201 participants (43.1%) had multimorbidity. Over a mean (SD) of 11.8 (2.2) years of follow-up, 6182 participants (3.0%) developed dementia. The incidence rate was 1.87 (95% CI, 1.80-1.94) per 1000 person-years for those without multimorbidity and 3.41 (95% CI, 3.30-3.53) per 1000 person-years for those with multimorbidity. In Cox proportional hazards models adjusted for age, sex, ethnicity, education, socioeconomic status, and APOE-ε4 carrier status, multimorbidity was associated with an increased risk of incident dementia (hazard ratio [HR], 1.63 [95% CI, 1.55-1.71]). The highest dementia risk was observed for the hypertension, diabetes, and coronary heart disease cluster (HR, 2.20 [95% CI, 1.98-2.46]) and pain, osteoporosis, and dyspepsia cluster (HR, 2.00 [95% CI, 1.68-2.37]) in women and in the diabetes and hypertension cluster (HR, 2.24 [95% CI, 1.97-2.55]) and coronary heart disease, hypertension, and stroke cluster (HR, 1.94 [95% CI, 1.71-2.20]) in men, compared with no multimorbidity. The associations between multimorbidity and dementia were greater in those with a lower genetic risk of dementia (HR, 1.96 [95% CI, 1.81-2.11]) than in those with a higher genetic risk of dementia (HR, 1.39 [95% CI, 1.30-1.49]). Similar findings were observed when stratifying diseases clusters by genetic risk for dementia. CONCLUSIONS AND RELEVANCE: These findings suggest that multimorbidity was associated with an increased risk of dementia. The associations varied by clusters of disease and genetic risk for dementia. These findings could help with the identification of individuals at high risk of dementia as well as the development of targeted interventions to reduce or delay dementia incidence. American Medical Association 2022-09-20 /pmc/articles/PMC9490497/ /pubmed/36125811 http://dx.doi.org/10.1001/jamanetworkopen.2022.32124 Text en Copyright 2022 Calvin CM et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Calvin, Catherine M.
Conroy, Megan C.
Moore, Sarah F.
Kuźma, Elżbieta
Littlejohns, Thomas J.
Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia
title Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia
title_full Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia
title_fullStr Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia
title_full_unstemmed Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia
title_short Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia
title_sort association of multimorbidity, disease clusters, and modification by genetic factors with risk of dementia
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490497/
https://www.ncbi.nlm.nih.gov/pubmed/36125811
http://dx.doi.org/10.1001/jamanetworkopen.2022.32124
work_keys_str_mv AT calvincatherinem associationofmultimorbiditydiseaseclustersandmodificationbygeneticfactorswithriskofdementia
AT conroymeganc associationofmultimorbiditydiseaseclustersandmodificationbygeneticfactorswithriskofdementia
AT mooresarahf associationofmultimorbiditydiseaseclustersandmodificationbygeneticfactorswithriskofdementia
AT kuzmaelzbieta associationofmultimorbiditydiseaseclustersandmodificationbygeneticfactorswithriskofdementia
AT littlejohnsthomasj associationofmultimorbiditydiseaseclustersandmodificationbygeneticfactorswithriskofdementia